SAN DIEGO, Feb. 4, 2026 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
